Baxdrostat
AstraZeneca
[]
first off from lbct at #acc23, dr. presents the results of the halo trial, a phase 2, double-blind, placebo-controlled trial the efficacy and safety of badrostat in patients with uncontrolled hypertension 
IM Resident @Rutgers_NJMS @univhospnewark. Previous @TuftsMedSchool, econ @NYUniversity. Team @cardionerds 🫀